With the offering, the Chinese electric vehicle company expects its cash reserves to exceed $2.9 billion.
The Chinese automaker says its extended-range technology "will help accelerate the adoption of electric vehicles in China."
In the first U.S. offerings since December, U.S. and Chinese biotech firms raised about $252 million.
